Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › CCR5 disruption of cells expressing anti-HIV chimeric antigen receptor (CAR) derived from broadly neutralizing antibodies

CCR5 disruption of cells expressing anti-HIV chimeric antigen receptor (CAR) derived from broadly neutralizing antibodies

US Patent 10494422 · Granted Dec 3, 2019

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods for treatment using chimeric antigen receptors specific for B-cell matur2025
Vivo gene therapy using intraosseous delivery of a lentiviralgene construct2025
Chimeric antigen receptors specific for B-cell maturation antigen and encoding p2025
Homology directed repair compositions for the treatment of hemoglobinopathies2025
Homology directed repair compositions for the treatment of hemoglobinopathies2025
Coupling endonucleases with end-processing enzymes drives high efficiency gene d2025
Methods of exogenous drug activation of chemical-induced signaling complexes exp2025
Codon-optimized nucleotide sequences encoding an AP-1 transcription factor2025
Optimized mRNA encoding CAS9 for use in LNPs2025
Viral vectors and packaging cell lines2025
ROR1 targeting chimeric antigen receptor2024
Homology directed repair compositions for the treatment of hemoglobinopathies2024